In addition, in the same study, the authors showed the potential of the dimeric CD28 aptamer to enhance the anti-tumor effect of the intradermal (Id) vaccine in A20 lymphoma-bearing mice following a vaccination protocol.16 The gene discussed is CD28; the disease is neoplasm.